6 research outputs found
Pulmonary Tuberculosis: Evaluation of Interferon-γ Levels as an Immunological Healing Marker Based on the Response to the Bacillus Calmette-Guerin
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis
whose interaction with the host may lead to a cell-mediated
protective immune response. The presence of interferon-γ
(IFN-γ) is related to this response. With the purpose of
understanding the immunological mechanisms involved in this protection,
the lymphoproliferative response, IFN-γ and other cytokines like
interleukin (IL-5, IL-10), and tumor necrosis factor alpha (TNF-α)
were evaluated before and after the use of anti-TB drugs on 30 patients
with active TB disease, 24 healthy household contacts of active TB
patients, with positive purified protein derivative (PPD) skin tests
(induration ≥ 10 mm), and 34 asymptomatic individuals with
negative PPD skin test results (induration ≤ 5 mm). The positive
lymphoproliferative response among peripheral blood mononuclear cells
of patients showed high levels of IFN-γ, TNF-α, and IL-10. No
significant levels of IL-5 were detected. After treatment with
rifampicina, isoniazida, and pirazinamida, only the levels of
IFN-γ increased significantly (p < 0.01). These results
highlight the need for further evaluation of IFN-γ production as a
healing prognostic of patients treated
Donor-Derived Tuberculosis: A Case Report and the Role of Communication Gaps in Transplantation Safety
Donor-derived tuberculosis (DD-TB) accounts for less than 5% of TB cases and is considered a rare event. In the transplant setting, the frequency of active TB is estimated to be 20 to 74 times higher than that in the general population, and it is associated with high mortality. In this context, the main strategy to minimize the risk of DD transmission is to identify high-risk donors. Despite screening recommendations, failures may result in a breakdown of safety that ends in the transmission of potentially fatal diseases. This report describes a case of DD-TB and emphasizes communication gaps that may occur between organ procurement organizations and transplant centers. Failure in reporting results, lack of exchanging information regarding recipients from the same donor, and inefficient communication between organ procurement organizations and transplant centers are lacks that may be prevented by a more efficient approach towards screening protocols and communication